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ABSTRACT
BACKGROUND: Haematological complications such as anaemia, neutropenia and thrombocytopenia are associated with 
Human Immunoeficiency Virus (HIV) disease progression and reduced survival. These have been documented to be the 
second most common cause of morbidity and mortality in infected children. This study sought to assess the 
haematological parameters in HIV positive Anti-retroviral therapy (ART)-naïve children and compare with the HIV negative 
children in order to discover ways of maximizing outcomes and value from ART when eventually indicated.
METHODS: This was a prospective observational study done in 2016 at University of Nigeria Teaching Hospital, Enugu, 
involving a total of 200 children. Blood samples were collected for full blood count (FBC) and Cluster of Differentiation 4 
(CD4) counts. Data generated were analyzed with Statistical Package for Social Sciences (SSPS) version 22. 
RESULTS: The prevalence of anaemia was 60% among HIV-infected children.Hemoglobin levels unlike leucocyte and 
platelet counts were significantly associated with HIV-infection. CD4 count was inversely associated with anaemia. 
Similarly the incidence of anaemia but not neutropenia and thrombocytopenia was also inversely and significantly 
associated with the ages of the children.
CONCLUSION:  Anaemia was prevalent among HIV infected children and is inversely associated withCD4 count. 
Haemoglobin concentration estimations can therefore be considered as one of the criteria for commencement of anti-
retroviral medications especially in resource poor centers where CD4 count is not readily available. 
KEYWORDS: HIV, Antiretroviral therapy naïve, Anaemia, Thrombocytopenia, CD4 count, Children.
Original Article 
INTRODUCTION
he Human Immunodeciency Virus (HIV) Tis one of the most important infections of this century. It is probably one of the 
diseases with multiple impacts on persons, 
families, communities and the entire society. Over 
3 million children were noted to be living with 
1
HIV around the world at the end of 2013.  
Haematological complications have been 
documented to be the second most common cause 
of morbidity and mortality in HIV positive 
2
p e r s o n s .  A  v a r i e t y  o f  h a e m a t o l o g i c a l 
manifestations, sometimes life-threatening, is 
seen at every stage of HIV infection impairing the 
3
quality of life of these patients. These pose a great 
challenge in the comprehensive management of 
4-5
such patients.  Haematological abnormalities 
have been documented as strong independent 
predictors of morbidity and mortality in HIV 
3
infected children. Although it is neither part of the 
criteria for initiating therapy nor used by the 
World Health Organization (WHO) for staging 
HIV, peripheral blood cell abnormalities with an 
abnormal haemogram are important prognostic 
3
tools for morbidity in HIV infection and AIDS.  
The presence of these complications in HIV 
infected ART-naïve patients usually result in poor 
treatment outcome when ART becomes indicated 
and strongly predict poor prognosis and increased 
6
mortality. . Infection with HIV ultimately leads to 
profound immunosuppression in which patients 
may present with various AIDS dening clinical 
conditions (which are a set of diseases associated 
with AIDS) that may impact negatively on his 
quality of life. Impaired haematopoiesis, 
immune-mediated cytopenias and altered 
coagulation caused by increasing viral load as the 
disease progresses may account for the Correspondence to: Adaobi I Bisi-Onyemaechi
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hematological abnormalities seen in HIV 
infection.  These abnormalities may occur as a 
result of the infection, as sequelae of HIV-related 
opportunistic infections or malignancies. 
Anaemia is the most common haematological 
7-9
abnormality in HIV-infected patients.  The 
consequences of untreated anaemia may lead to 
multisystem disabling symptoms and fatigue, 
exhaustion, increased risk of HIV dementia and 
10poor quality of life.  Thrombocytopenia is also a 
9,11-12
frequent complication of HIV infection. The 
possible mechanisms that have been reported are 
immune-mediated destruction of platelets by 
antibodies and cross-reacting antibodies that are 
13directed towards HIV proteins.
Thrombocytopenia has also been identied as a 
strong independent predictor for mortality in HIV 
14
positive patients.  Neutropenia is the most 
common leucopenia occurring in HIV infected 
9
individuals. HIV infection suppresses the bone 
marrow and leads to decreased levels of 
9
granulocyte colony-stimulating factor.  Low CD4 
count has been associated with anaemia, 
15neutropenia and thrombocytopenia.  . HIV 
preferentially infects CD4 cells causing their 
destruction. This study was to assess those 
haematological parameters in ART-naïve HIV 
positive patients and compare them to HIV 
negative subjects.
Africa is the epicenter of the HIV pandemic as 
reported the World Health Organization (WHO) 
and Sub Saharan Africa contributes about 60% of 
the burden worldwide. About 3.4 million 
Nigerians were living with the virus in 2012 which 
16represents a national prevalence of 5.8%.
In Nigeria and most Sub-Saharan Africa, HIV 
patients are mostly dependent on donor 
medications from the developed nations hence 
there is need for continuous research to improve 
the treatment outcomes and add value on the huge 
resources spent on the treatment of HIV infection 
and AIDS disease
METHODOLOGY 
Study setting and study population
This was a prospective observational study 
conducted at the HIV clinic of the University of 
Nigeria Teaching Hospital, Enugu from July 13, 
2015 to November 20, 2015. HIV infected children 
(1 to 12 years) who were not yet on antiretroviral 
medications and whose parents consented, were 
recruited consecutively into the study. Febrile and 
malnourished children were excluded from the study.
Ethical considerations
Ethical clearance was obtained from the Ethical 
and Research committee of University of Nigeria 
Teaching Hospital before commencement of the 
study. An informed consent form was lled and 
signed by all consenting caregivers.
Data collection
Medical and demographic information were 
obtained from all the study participants using a 
proforma. Blood for full blood count was 
collected using an EDTA bottle. Samples were 
then analyzed using an auto analyzer. Two weeks 
later a second sample was collected from the same 
participants and those with consistent values on 
both occasions were enrolled. Anaemia was 
dened as hemoglobin level less than 10 
grams/deciliter. The CD4 count was done using 
the Becton Dickinson FACS Calibur system.
Statistical analysis 
The data were then analyzed with Statistical 
Package for Social Sciences (SPSS) version 22 of 
the IBM Corporation. Descriptive statistics were 
used to summarize categorical and continuous 
variables. Median values of absolute neutrophil 
count and platelet (skewed variables) were 
comparedbetween tests and age/sex matched 
controls using Mann-Whitney U test while mean 
values of haemoglobin concentration were 
compared between the same groups using 
Student's t-test. Relationships between age, CD4 
count and haematological parameters were 
determined using correlation and linear 
regression. Associations between HIV statuses, 
different levels of CD4 count and haematological 
abnormalities were tested using logistic 
regression and Chi-square. The statistical 
signicance was set at p < 0.05. Results were 
presented in tables, charts and scatter plots.
RESULTS
A total of 200 children (100 HIV Positives and 100 
controls) were enrolled into the study, all 
matched for sex and age. There were 48 males and 
52 females with ratio of approximately 1:1 (Table 
i). The age ranged from 1 to 12 years with a mean ± 
Standard Deviation (SD) of 5.59 ± 3.25 years.
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Table 1: Sex and age distribution of all study participants
Among the study participants, the absolute 
neutrophil counts (ANC) ranged from 572 to 
3 18711 cells/mm with mean ± SD of 3176 ± 2469 
3
cells/mm  while amongst the controls, the ANC 
3
ranged from 105 to 12450 cells/mm with mean ± 
3SD of 3966.14 ± 2646.14 cells/mm. )  The median 
ANC for the HIV positive subjects 2428.50) and 
the controls (3320.00) were not signicantly 
different. (p = 0.115).
Mean platelet levels in infected children were 
3
323900.00(SD ± 129147.67) cells/mm , range 
326000 -708000 cells/mm  while in the controls, 
3mean was 312000(SD ± 290000.00 cells/mm ) 
3
and range 112000 -975000 cells/mm . The 
difference in the median platelet levels for the 
test subjects and the test controls were not 
signicantly different. (p = 0.226).
The mean haemoglobin concentrations in infected 
c h i l d r e n  a n d  u n i n f e c t e d  c h i l d r e n 
were9.44g/dl(SD± 1.44) range 5.20 -12.20g/dl and 
10.67g/dl (SD ± 1.24), range 6.60 - 15.30g/dl 
respectively. There was a normally distributed 
haemoglobin concentration values in both groups. 
Table II shows the prevalence of haematological 
abnormalities among the study participants. The 
prevalence of anaemia was 60% and 23% among the 
infected and uninfected respectively.(Table iii) 
Anaemia is 5 times more signicantly associated 
with the HIV infection than test controls (p < 0.001, 
OR = 5.022, 95% C.I = 2.718 – 9.279). Neutropenia was 
seen in 18 sero-positive (11 males and 7 females) and 
in 14 sero-negative (9 males and 5 females) study 
participants (p = 0.441). The prevalence of 
thrombocytopenia is 7% among the test subjects and 
6% among the test controls. (p = 0.774).
Table 2: Relationship between prevalence of haematologic abnormalities in HIV 
infected subjects and controls
          Infected      Control  p value  OR  95% C.I for OR  
Haemoglobin      
Anaemia             60          23  < 0.001  5.022  2.718 –  9.279  
Normal
             
40
         
77
    
Neutrophil Count
      Neutropenia
             
18











             
82
         
86
    Platelet count
      Thrombocytopenia
               
7











             
93
         
94
    
Haemoglobin, unlike neutrophil and platelet concentration had a signicant positive but weak 
relationship with age in infected children (p < 0.001, r = 0.348)(Table iii)








Pearson Correlation (r)  -0.110  -0.077  0.348  
















Table 3: Relationship between age and haematological parameters in HIV infected 
participants.
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Table 4: Relationship between levels of haematological parameters and CD4 count of the 
infected children.
No signicant relationship was found with 
neutrophil levels, platelet levels and haemoglobin 
concentration among the controls.
The overall minimum CD4 count was 4 cell/mm3 
and the maximum was 2098 cells/mm3 with a 
median CD4 count of 350 cells/mm3. Eighteen 
percent (18/100) of the study population had CD4 
counts of  < 200 cells and 19% (19/100) of them 
had CD4 counts <between 200 and 500 cells. 
Majority of the study population 63% (63/100) 
had CD4 above 500 cells. There was a signicant 
relationship between haemoglobin concentration 
and CD4 count in the infected children (p = 0.016). 
(Table IV). The correlation coefcient (R = 0.240) 
indicated a weak positive relationship existing 
between the two variables. The coefcient of 
determination (R2 = 0.058) indicated that little 
changes in haemoglobin concentration can be 
explained by CD4 count while regression 
coefcient (B = 0.001) indicated a positive effect of 
CD4 count on haemoglobin concentration. There 
is no signicant relationship between CD4 count 
and absolute neutrophil count, p = 0.239 and 
between CD4 count and platelet count, p = 0.367.
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Table 5: Comparison of haematological parameters in male and female test subjects.
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There was a signicant positive but weak relationship existing between haemoglobin concentration and 
CD4 count in the HIV positive ART-naïve children. (Fig 1)
The cluster of points does not follow any regular pattern indicating no signicant relationship between 
neutrophil levels and CD4 count of the subjects. There was also no signicant relationship between 
platelet levels and CD4 count of the HIV infected study participants
                           
Figure 1: A scatter diagram showing the relationship between haemoglobin levels and CD4 count of 
the infected children.
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DISCUSSION
A 60% prevalence of anaemia in this study is 
comparable to 64% prevalence in another 
17study. In both studies anaemia was diagnosed as 
hemoglobin less than 10g/dl. However, this 60% 
prevalence in this study was signicantly higher 
than the ones reported by some authors who 
18-19
reported 28.1% and 35% respectively. Good 
adherence to follow-up and general improvement 
in living conditions was attributed for the 
relatively lower prevalence. Pasha documented 
high prevalence rate of 89% although anaemia 
was diagnosed as haemoglobin concentration less 
20than 12g/dl in their study.
The difference in haemoglobin concentration of 
HIV-infected and uninfected children have also 
17,21
been documented previously.  Possible reasons 
are bleeding from possible gastrointestinal 
malignancy, severe infection, poor nutritional 
intake (iron, cobalamin, folate, iron, general), 
haemolytic anaemia, changes in erythropoietin 
synthesis and/or bone marrow suppression.
Also,  the dif ference in  the hemoglobin 
concentration between the genders was not 
signicant statistically, although some authors 
reported a higher prevalence of anaemia in 
22-23females.  Reasons for this nding are not clear 
however previous studies which reported higher 
prevalence of anaemia in females were done in 
adult females where menstruation, pregnancy and 
child birth may have contributed to iron depletion.
The positive but weak relationship between 
increasing age and haemoglobin concentration 
21was also corroborated by Ferede. No such 
relationship was found in the test controls. As the 
CD4 count  increased,  the  haemoglobin 
concentration also increased. This nding is 
19,24
supported by other reports.
The prevalence of neutropenia in this study was 
18% in the test subjects and 14% in the test 
controls. This 18% prevalence was higher 
compared to the studies done by Amballie et al 
25
which showed prevalence of 6% and 10% 
respectively. The difference may be due to 
variation in study population which were adult 
patients, study design method which was a 5 year 
retrospective review of case notes of patients. The 
increase or decrease in ages of both the infected 
and the test controls had no effect on the absolute 
neutrophil counts. This is not unexpected as ANC 
is not known to vary with age after infancy. 
In this study, there was no signicant relationship 
between neutropenia and CD4 counts. This was in 
26
contrast to the studies byCalenda who reported 
signicant association between neutropenia and 
CD4 counts. The 7% thrombocytopenia in the 
positive children was higher than a previous 
report in the study area that showed a prevalence 
19
of 5.9%. An Indian study has also reported a 
27
lower prevalence (4.65%) of thrombocytopenia.  
Higher results in this study may be due to the 
difference in the study population(which were 
children unlike the previous reports) or  
environmental factors as there was no statistical 
difference between the infected and the controls in 
our study. However, a prevalence of 20% in 
28
thrombocytopenia was reported from Iran.  The 
reason for this high prevalence of 20% may be 
attributed to the late presentation of their patients 
and the higher cut off value used to dene 
thrombocytopenia(platelet count less than 
100,000 per micolitre of blood while 50,000 was 
used in this study). Advanced HIV infection have 
29
been documented to worsen thrombocytopenia
R e a s o n s  f o r  t h e  h i g h e r  p r e v a l e n c e  o f 
thrombocytopenia in female infected children is 
not clear.There were no relationship between age 
and thrombocytopenia in this study. This was 
28
corroborated in the study by Alaei. The CD4 
count of the study participants did not show 
signicant association with thrombocytopenia 
unlike a report from North West Ethiopia where 
reducing CD4counts was associated with 
19increasing risks of thrombocytopenia.
CONCLUSION
This study shows that anaemia is quite common 
among HIV positive ART-naïve children and was 
more prominent with decreasing age. It was also 
noted anaemia was a weak predictor of CD4 
count.
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